BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND Neurokinin
16 results:

  • 1. IFN-α/β-mediated NK2R expression is related to the malignancy of colon cancer cells.
    Xiang H; Toyoshima Y; Shen W; Wang X; Okada N; Kii S; Sugiyama K; Nagato T; Kobayashi H; Ikeo K; Hashimoto S; Tanino M; Taketomi A; Kitamura H
    Cancer Sci; 2022 Aug; 113(8):2513-2525. PubMed ID: 35561088
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences.
    Nizam E; Köksoy S; Erin N
    Cancer Immunol Immunother; 2020 Aug; 69(8):1639-1650. PubMed ID: 32322911
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.
    Sha YL; Liu S; Yan WW; Dong B
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31511432
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Substance P and fibrotic diseases.
    Peng L; Agogo GO; Guo J; Yan M
    Neuropeptides; 2019 Aug; 76():101941. PubMed ID: 31256921
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells.
    Huang C; Li Y; Guo Y; Zhang Z; Lian G; Chen Y; Li J; Su Y; Li J; Yang K; Chen S; Su H; Huang K; Zeng L
    Theranostics; 2018; 8(11):3074-3086. PubMed ID: 29896303
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Therapeutic Innovations for Targeting Hepatoblastoma.
    Garnier A; Ilmer M; Kappler R; Berger M
    Anticancer Res; 2016 Nov; 36(11):5577-5592. PubMed ID: 27793881
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. neurokinin A monitoring of response to interferon alpha in a patient with an advanced small bowel neuroendocrine tumour uncontrolled by somatostatin analogue therapy.
    Ardill JE; Johnston BT; McCance DR; Eatock M
    Ann Clin Biochem; 2017 Mar; 54(2):297-301. PubMed ID: 27638929
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeting the neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma.
    Ilmer M; Garnier A; Vykoukal J; Alt E; von Schweinitz D; Kappler R; Berger M
    Mol Cancer Ther; 2015 Dec; 14(12):2712-21. PubMed ID: 26516161
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Involvement of substance P and the NK-1 receptor in human pathology.
    Muñoz M; Coveñas R
    Amino Acids; 2014 Jul; 46(7):1727-50. PubMed ID: 24705689
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Involvement of substance p/neurokinin-1 receptor in the analgesic and anticancer activities of minimally toxic fraction from the traditional Chinese medicine Liu-Shen-Wan in vitro.
    Li XJ; Jia MM; Li YS; Yang YL; Mao XQ; Tang HB
    Biol Pharm Bull; 2014; 37(3):431-8. PubMed ID: 24366059
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs).
    Tellez MR; Mamikunian G; O'Dorisio TM; Vinik AI; Woltering EA
    Pancreas; 2013 Apr; 42(3):405-10. PubMed ID: 23160483
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.
    Turner GB; Johnston BT; McCance DR; McGinty A; Watson RG; Patterson CC; Ardill JE
    Gut; 2006 Nov; 55(11):1586-91. PubMed ID: 16556667
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Granisetron: an update on its clinical use in the management of nausea and vomiting.
    Aapro M
    Oncologist; 2004; 9(6):673-86. PubMed ID: 15561811
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.
    Balks HJ; Conlon JM; Creutzfeldt W; Stöckmann F
    Eur J Clin Pharmacol; 1989; 36(2):133-7. PubMed ID: 2470592
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Isolation and characterization of neurokinin A, neurokinin A(3-10) and neurokinin A(4-10) from a neutral water extract of a metastatic ileal carcinoid tumour.
    Theodorsson-Norheim E; Jörnvall H; Andersson M; Norheim I; Oberg K; Jacobsson G
    Eur J Biochem; 1987 Aug; 166(3):693-7. PubMed ID: 3038549
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.